ABI Targets Q4 for Worldwide Sales of Its Expression Analysis Microarray Platform | GenomeWeb

Applied Biosystems will first commercialize its Expression Analysis platform in Japan, officials said last week as the company announced its fiscal second-quarter earnings.

“We expect to begin unrestricted sales of the Applied Biosystems Expression Array System in Japan during the current quarter, and in the rest of the world during the fourth fiscal quarter,” Mike Hunkapiller, president of Applied Biosystems said in a conference call with financial analysts on Wednesday, Jan. 28. The company’s fiscal second quarter ended Dec. 31.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.